Differential diagnosis of diseases that share common clinical signs typically requires the performance of multiple independent diagnostic tests to confirm diagnosis. Diagnostic tests that can detect and discriminate between multiple differential pathogens in a single reaction may expedite, reduce costs, and streamline the diagnostic testing workflow. Livestock haemorrhagic diseases like classical swine fever (CSF), African swine fever (ASF), and vesicular diseases, such as foot-and-mouth disease (FMD), vesicular stomatitis (VS), and swine vesicular disease (SVD) can have an enormous impact on the livestock industry and economy of countries that were previously free of the diseases. Thus, rapid diagnosis of these diseases is critical for disease control.
| INTRODUCTION
Livestock and their products are an important part of the global economy and food supply chain. In 2017, global beef and veal production amounted to approximately 61.4 million metric tonnes, while pork production was about 111 million metric tonnes (https:// www.fas.usda.gov/data/livestock-and-poultry-world-markets-andtrade). Infectious diseases such as foot-and-mouth disease (FMD), classical swine fever (CSF), and African swine fever (ASF) are highly contagious viral diseases reportable to the OIE (World Organization for Animal Health). These diseases can have a severe economic impact on affected areas due to production losses and international trade of animals and animal products with disease free countries.
For example, the 2001 FMD outbreak in the United Kingdom resulted in the slaughter of approximately 6 million animals and had an estimated cost of $13 billion U.S. (Thompson et al., 2002) . A similarly large economic impact was demonstrated in the [1997] [1998] classical swine fever (CSF) epizootic in the Netherlands. In this case, excluding the loss of exports, the economic cost amounted to approximately US $2 billion and resulted in the slaughter of approximately 10 million pigs (Terpstra & de Smit, 2000) .
FMD affects over 70 species of cloven-hoofed animals including cattle, pigs, sheep, goats, and wild ruminants causing vesicular lesions on the mouth and hoof (Hedger, Condy, & Gradwell, 1980) . (Costard et al., 2009; Giammarioli, Pellegrini, Casciari, & Mia, 2008 ) that is clinically indistinguishable.
For the molecular diagnosis of FMD, SVD, VS, CSF, and ASF, the OIE currently recommends methods such as PCR, including real-time PCR. Conventional and real-time RT-PCR assays have been developed for CSFV (Wernike, Hoffmann, & Beer, 2013) , ASFV (Fernán-dez-Pinero et al., 2013) , FMDV (Hole, Clavijo, & Pineda, 2006; King et al., 2006; Reid et al., 2009) , VSV (Hole et al., 2006; Rasmussen, Uttenthal, & Agüero, 2006) and SVDV (Fernández et al., 2008; Núñez et al., 1998) . Novel user-friendly reverse transcription insulated isothermal PCR (RT-iiPCR) assays performed on compact, field deployable instruments with automatic display of "+" or "−" results have also been described for CSFV (Lung et al., 2015) and FMDV . Although RT-iiPCR and real-time RT-PCR are rapid and highly sensitive, separate single target reactions are normally performed when testing for the presence of multiple pathogens. The need to perform multiple tests for each sample and separate manual handling for nucleic acid extraction and PCR by experienced technicians can increase the total cost and hands-on time needed to obtain results.
In this study, we describe the development and initial laboratory validation of a user-developed fully automated and integrated nucleic acid detection assay for simultaneous detection of the genome of multiple high consequence livestock viruses. The new assay utilizes a microfluidic CARD (Chemistry and Reagent Device) that integrates magnetic bead-based nucleic acid extraction, conventional PCR/RT-PCR, and capture probe hybridization-based reverse dot blot detection. Each CARD can process up to four samples and up to six CARDs can be processed simultaneously on an Encompass Optimum workstation. The fully automated and integrated multiplex assay can simplify the workflow for multipathogen detection for surveillance and early detection of infectious diseases.
| MATERIALS AND METHODS

| Virus
Virus isolates, RNA, and DNA used in this study were from archived materials available at the CFIA National Centre for Foreign Animal Disease Laboratories (NCFAD) in Winnipeg, Manitoba and National Centres for Animal Disease (NCAD) Lethbridge Laboratory in Lethbridge, Alberta (Table 1) . Clinical samples were obtained from animals that had been experimentally inoculated with the target viruses as part of previous research projects and included oral fluid, oral swabs, nasal swabs, whole blood, serum, as well as postmortem tonsil, spleen, kidney, and ileum (Senthilkumaran et al., 2016 (Senthilkumaran et al., , 2017 ( Table 2 ). All animal experiments were approved by the institute's Animal Use Committee.
| Primers and probes
Primers and capture probes were either modified from published literature, adopted from unpublished in-house assays, or designed as part of this study using methods described previously (Lung et al., 2011 (Lung et al., , 2012 (Lung et al., , 2015 and are presented in Tables 3 and 4, respectively. All reverse primers were designed with a spacer sequence and biotin modification on the 5′-end. Probes were designed with a 5′ amino C6 modification.
| Multiplex reverse transcriptase (RT) PCR
Two multiplex RT-PCRs were developed: one had 11 primers targeting SVDV 3C/3D, VSV L, CSFV 5′ UTR and ASFV p72 genomic regions; the second RT-PCR had two primers targeting FMDV polymerase coding region and two primers for the β-actin endogenous control. The RT-PCR mixtures consisted of 1 μl of nucleic acid, 1 μl of Superscript III one-step RT-PCR enzyme mix (ThermoFisher), 0.5 μM of each primer (except the VSV-NJ primers which were used at 1 μM to improve sensitivity) in 1x reaction buffer (ThermoFisher) and topped up with UltraPure Distilled Water (Sigma-Aldrich) to a LUNG ET AL. 
| Off-CARD filter testing and probe evaluation
Initial detection probe screening was conducted on filters that were manually spotted with probes (20 μM,~0.5 μl) using a micropipette, then washed with 0.1 N sodium hydroxide for 2 min to block nonspecific reactivity, rinsed in nuclease-free water at room temperature twice for 2 min and placed in SS buffer (1× SSPE buffer, 0.1% sodium dodecyl sulphate) at 50°C for 15 min with agitation (800 rpm). Amplicons from a conventional thermocycler were heat denatured at 95°C for 10 min, snap cooled on ice for 5 min, mixed with SS buffer, added to a microcentrifuge tube containing a spotted filter, and hybridized at 40°C for 15 min. Following hybridization, filters were washed with SS buffer at 50°C for 10 min, washed again with fresh SS buffer at room temperature for 10 min and then treated with a streptavidin-horseradish peroxidase solution (HRP, 1 mg/ were washed in fresh SS buffer at room temperature for 10 min a total of three times and then treated for 7 min at room temperature with TMB-Blotting 1-Step Solution (ThermoFisher) for colorimetric detection. Finally, filters were transferred from TMB to nuclease-free water in order to prevent over exposure and then filters were imaged and results were analysed. A final set of detection probes was selected based on reactivity and specificity, then custom-printed onto filters with probes for another project, and mounted onto CARDs by Rheonix
Inc. for testing on the Encompass Optimum workstation (Rheonix, Inc.).
| CARD assay development
The Rheonix Encompass workstation is a "sample-to-answer" platform that can process up to six CARDs automatically in a single run under the control of computer software. The primers and probes used in this assay were either modified from published literature or designed inhouse. The assay uses an existing four sample CARD design, guanidine magnetic bead-based nucleic acid purification process, two independent RT-PCR amplifications, and a reverse dot blot detection procedure ( Figure 1b) . One of the two independent PCR chambers was used for amplification of FMDV and the β-actin internal control and 
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Petrov, Beer, and Blome (2014) ß-actin-R /5′-biotin/5′-spacer/CSGACTCRTCGTACTCCTGCTT /5′-spacer/ = GCAGTATATCGCTTGACA. were custom-printed on nylon filters and mounted onto CARDs. The assays were transferred from off-CARD to on-CARD testing in a progressive fashion, where the RT-PCR and detection subcomponents of the assay were first manually optimized on the benchtop before fullintegration with the nucleic acid extraction subcomponent of the assay on the CARD and processed with the automated workstation.
T A B L E 4 Probes used in this study
The final RT-PCR and hybridization conditions were the same as those evaluated with the off-CARD protocol except the VSV-NJ primers were added to the RT-PCR at 1 μM to improve sensitivity.
| Sample pretreatment and CARD testing
Since Canada is free of the diseases caused by the five main targets of the assay, all of the work was carried out in a containment level 3 (CL 3) laboratory. Due to biosafety considerations, all samples were first processed by adding 100 μl of sample to 100 μl of MagMax lysis buffer (ThermoFisher) and incubating for 10 min in a biosafety cabinet (BSC). The 200 μl of sample and lysis buffer mixture were then added to separate sample lanes on a CARD in the BSC instead of using the software-controlled sample loading procedure from the sample rack on board the instrument. CARDs loaded with sample were then put onto the workstation for testing, along with racks of pipette tips (Tecan) and a preloaded reagent pack (Rheonix Inc.) containing all required nucleic acid extraction and signal detection reagents (e.g., lysis buffer, washing buffer, elution buffers). However, PCR master mix, PCR primers specific for the assay and enzymes for RT-PCR were prepared separately. The run was initiated and all remaining steps through data collection were conducted automatically using instrument software. Sixteen samples with discordant results between the CARD assay and archived results for standard real-time assays used at the CFIA were repeated. All 16 samples had the same CARD result as the initial test, while some of the samples that were positive based on archived real-time PCR data were negative upon retest and the more recent data were used.
| Data analysis
For initial assay development, signal intensity values captured by the instrument were exported, analysed quantitatively in Excel and displayed as heatmaps. In order to streamline data analysis, a python script was developed to automatically extract and format data collected for each sample in a run into a single summary 
| Limit of detection
Ten-fold and 2-fold serial dilutions of titred viruses in Ultrapure water (Sigma) were tested with the CARD assay. Samples were processed for testing as described above for laboratory and clinical samples. Dilutions were tested in duplicate and considered positive if at least one was above the established cut-off. 3 | RESULTS
|
| RT-PCR amplification subcomponent optimization
The fully automated assay utilizes a Rheonix Encompass Optimum workstation ( Figure 1a ) with an embedded computer that can control final concentration of 100 μg/ml to stabilize the polymerase and to protect it from inhibitors and adsorption to vessel walls. In addition, the volume of polymerase used in the reaction was doubled and the volume of extracted material added to the reaction was reduced from 2 μl to 1 μl to mitigate the effects of any inhibitors inherent in the sample. Furthermore, reverse primers were modified by adding an internal spacer between the 5′-biotin group and the reverse primer sequence to enhance reaction signals.
| Detection of laboratory amplified viruses with the CARD assay
An expanded panel of 37 laboratory amplified virus samples representing the five target viruses, and 15 nontargets was tested on CARD ( Table 1) F I G U R E 2 Representative images of the final post-HRP results observed after completion of fully integrated CARD assays. (a) Layout of the capture probes on the CARD filter used in this study with detection probes for another project blacked out. (b) Camera images of the detection of a representative set of target and nontarget viruses using the CARD assay. The pathogen-specific probes are outlined in grey. The three spots at the top right, bottom left, and bottom right corners represent the "spotting control" which reacts with the HRP conjugate without the need for amplicon binding to ensure the signal detection reagents and process is working properly. These controls are also used to determine the orientation of the images for automated data collection and analysis. In addition, an endogenous internal control targeting β-actin gene was included and located beside one of the spotting controls in the bottom right corner (Table 5 ).
FMDV and SVDV were both detected at 1 dpi ( Figure 4 ) and VSV-IND 97CRB was detected at 2 dpi (Table 5 ). In addition, the multiplex CARD assay detected: ASFV in swine oral swab, nasal swab, and whole blood; CSFV in swine tonsil, spleen, kidney, ileum, and lymph node samples; and VSV in bovine oral and nasal samples (Table 5) . (Table 5 ). The comparison of relative sensitivity, specificity, and agreement between the multiplex CARD assay and each of the singleplex real-time RT-PCR assays is shown in Table 6 . The results show 100% specificity for all targets and 91% agreement between the multiplex CARD assay and singleplex real-time PCR results (Table 6 ).
| Limit of detection
The limit of detection of the multipathogen integrated CARD assay was determined using serial dilutions of the titred viruses. The multipathogen assay was most sensitive for detection of FMD, SVD, and ASF viruses and least sensitive for VSV (Table 7) .
| DISCUSSION
The Encompass Optimum workstation is a novel "sample-to-answer" platform that fully automates and integrates nucleic acid extraction, multiplex PCR amplification, end-point reverse dot blot detection, and data analysis into a single assay using microfluidic CARDs. It is designed such that the only technician intervention required is preparing the sample and reagent deck: loading samples into a sample rack, a reagent pack and tips into the reagent deck, then selecting a diagnostic program and initiating the test to be performed either using the touch screen on board the instrument or using an attached keyboard as was performed in this study. User-friendly software then automatically controls the entire progression of the assay, analysis, and reporting of the result. This level of "push-button" automation, integration, and multiplexing capability can improve test accuracy and reduce the hands-on labour and cost associated with diagnostic testing of multiple pathogens. In this study, filters with 27 features including three spotting and image orientation controls were used. This allows testing of up to 24 different detection probes for user-selected genetic targets (including an internal β-actin positive control and a nonspecific binding negative control probe) for one or more assays for each sample. For example, capture probes for another project were included on the same filters used in this study, making it possible for a CARD to be useful for multiple diagnostic tests.
Of the 144 clinical samples tested by the multiplex CARD assay, 
Viral Sample
FMDV (17) CSFV (6) VSV (7) SAT3 (2) 1.1 1.2 1.3 SAT2 (2) Non-targets (15) A (4) O (3) C (2) Asia (2) SAT1 (2) SAT2 (2) SAT3 (2) ASFV (3) SVDV (4) IND (3) NJ (4) PEV (3) BTV (2) PesƟ. (2) CSFV (4) VSV (2) VSV-NJ (2 Labour costs constitute a substantial part of the operations of a diagnostic laboratory. Thus, integrated and automated multiplex assays that require minimal manual handling and multiple pieces of instrument may improve the efficiency for disease surveillance. In this study, we provide an initial laboratory validation of a novel fully automated multiplex assay for high consequence livestock viral pathogens.
As this is a new user in-house developed assay and due to specific institutional biosafety requirements, a few of the instrument features were not integrated in this study. Automated sample loading using the sample rack was not used to allow an extra incubation step with lysis buffer in a BSC. Thus, sample loading on to the CARD was also performed in a BSC by pipetting the sample and lysis buffer mixture manually into the sample port on the CARD. The PCR master mix and PCR primers used in this study were not part of the reagent pack which contained all other reagents needed for the assay. Instead, the PCR reagents were prepared fresh with each run and placed on the reagent deck. This allows convenient modification of the assay by the user such as separating the current 5-plex assay into a 3-plex vesicular disease assay for FMD, SVD, VS and a separate duplex assay for CSF and ASF that can use the same CARDs and reagent packs. Alternatively, once the PCR primers, enzymes and master mix are finalized, they can be incorporated into the reagent pack as lyophilized reagents. Data analysis was initially performed manually using Excel rather than a new on board data analyser which was not available until the end of this study. However, subsequent reanalysis of the data with the automated data analyser resulted in identical results. 
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